DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Regeneron News

Johnson & Johnson to Invest $2 Billion in Holly Springs Facility Creating 120 Jobs Amid Trump’s 250% Drug Tariffs

Johnson & Johnson to Invest $2 Billion in Holly Springs Facility Creating 120 Jobs Amid Trump’s 250% Drug Tariffs

22

6 months ago

Regeneron’s Cemdisiran and Pozelimab Combo Shows Positive Phase 3 Results in Myasthenia Gravis With Near-Complete C5 Suppression

Regeneron’s Cemdisiran and Pozelimab Combo Shows Positive Phase 3 Results in Myasthenia Gravis With Near-Complete C5 Suppression

9

5 months ago

Any myostatin inhibitor FDA approved by 2027

Jun 29, 6:02 PMDec 31, 11:59 PM

62.55%chance

4117

OptionVotes

NO

YES

129

77

Latest stories

Aug 26, 2025
Aug 26, 2025
Health
Pharma
Science
Regeneron’s Cemdisiran and Pozelimab Combo Shows Positive Phase 3 Results in Myasthenia Gravis With Near-Complete C5 Suppression
Authors
9
5 months ago
Aug 21, 2025
Aug 21, 2025
Tariffs
Politics
Business
Johnson & Johnson to Invest $2 Billion in Holly Springs Facility Creating 120 Jobs Amid Trump’s 250% Drug Tariffs
Authors
22
6 months ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join